002172 澳洋健康
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)12.86735.51871.964-28.627-204.613
总资产报酬率 ROA (%)0.9021.8902.008-0.471-20.272
投入资产回报率 ROIC (%)1.2782.6872.754-0.681-28.046

边际利润分析
销售毛利率 (%)15.08613.38613.48513.9407.517
营业利润率 (%)5.2113.3643.7720.412-36.105
息税前利润/营业总收入 (%)7.0244.8174.7313.166-31.024
净利润/营业总收入 (%)4.1702.0522.312-0.778-35.234

收益指标分析
经营活动净收益/利润总额(%)99.25291.05979.409-519.66629.931
价值变动净收益/利润总额(%)-1.117-2.01429.6901,647.5440.369
营业外收支净额/利润总额(%)2.624-3.732-17.216963.344-1.386

偿债能力分析
流动比率 (X)0.6600.6540.6450.7230.804
速动比率 (X)0.5620.5670.5550.6530.757
资产负债率 (%)93.45994.38296.66299.01098.670
带息债务/全部投入资本 (%)81.76982.61593.11293.65189.734
股东权益/带息债务 (%)12.81811.3456.3662.3312.828
股东权益/负债合计 (%)7.9886.9494.3331.6481.674
利息保障倍数 (X)4.2003.0603.1260.985-6.763

营运能力分析
应收账款周转天数 (天)60.84052.20150.157135.98691.839
存货周转天数 (天)37.10734.42334.36735.20727.735